This bulletin pertains to existing and future IRB studies that use the Short Form consent method to enroll research participants who speak languages other than English.Change in IRB Requirements:
On Monday, November 4th, the UCSF IRB will release the following forms in iRIS:
Add Relying Site form (New)
Modification form (Updated)
Application form (Updated)
Detailed information about these forms will be provided on November 4th. Until then, here is a brief description of the upcoming…
Please note that there will be fewer IRB meetings in November, December, and January because of the holiday schedule.
If your study requires review by a convened IRB committee (i.e., “Full Committee”) and is set to expire in November, December, or January, please submit your continuing review at…
Coming Soon: IRB Form for Adding Relying Sites
On Monday, November 4th, the IRB will release a new form in iRIS called the “Add Relying Sites” form.
Detailed guidance will be shared closer to the release date. For now, here are the key things to know:
When should the Add Relying Sites form be…
Pediatric Hematologist-Oncologist and Oakland IRB Chair Jennifer Michlitsch, MD, is a specialist in pediatric blood diseases who is also passionate about increasing access to care and clinical trials for all children and their families. This passion for providing care for all patients also…
Mount Zion IRB Chair Alan Venook, MD, has a long history of serving on the IRB. A medical oncologist with expertise in gastrointestinal cancers, Venook understands the intricacies of conducting complex studies while upholding ethical standards.
We spoke with Alan about his work on the IRB, the…
On April 17th, the IRB issued a bulletin announcing a New Study Site Changes Form & Updated Modification Form that would be released on Monday, May 13th. We received valuable stakeholder feedback in response to that bulletin, and are changing the plan as follows: